Explore how artificial intelligence and informatics are transforming cancer drug discovery and development between 2018-2022, accelerating treatments and improving patient outcomes.
Exploring the molecular revolution transforming diagnosis and treatment of soft tissue sarcomas through genetic profiling and targeted therapies.
Explore how the National Cancer Institute's investment in biomechanics research is revolutionizing our understanding of cancer's physical properties and treatment approaches.
Exploring the molecular differences in colorectal cancer between younger and older patients, and what this means for diagnosis and treatment.